{4-Bromo-2-[(2-{(ethyl­sulfan­yl)[(2-oxidobenzyl­idene-κO)amino-κN]methylidene}hydrazinyl­idene-κN (1))meth­yl]phenolato-κO}(butan-2-ol-κO)dioxidouranium(VI)

The U(VI) cation in the title complex, [U(C(17)H(14)BrN(3)O(2)S)O(2)(C(4)H(10)O)], exists within a distorted penta­gonal–bipyramidal geometry, where the oxide atoms occupy the axial positions [O—U—O = 179.8 (3)°] and the penta­gonal plane is defined by the N(2)O(2) atoms of the tetra­dentate Schiff base ligand and the O atom of the 2-butanol mol­ecule. In the crystal, centrosymmetric aggregates are formed via pairs of hy­droxy–phenolate O—H⋯O hydrogen bonds. The azomethine C=N atoms, the ethyl­thiolyl group, the 2-butanol mol­ecule and Br atom are disordered over two positions in a 0.627 (3):0.373 (3) ratio.